Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 15.5B | 15.0B | 14.9B | 14.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 6.5B | 6.3B | 6.5B | 6.9B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 4.2B | 12.0B | 3.3B | 4.0B |
| Tax provision | 905M | 985M | 698M | 534M |
| Net income | 3.3B | 11.1B | 2.8B | 3.6B |
| Basic EPS | 1.9 | 6.3 | 1.6 | — |
| Diluted EPS | 1.9 | 6.3 | 1.6 | — |
| Basic average shares | 1.7B | 1.7B | 1.7B | — |
| Diluted average shares | 1.7B | 1.7B | 1.8B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 3.3B | 11.1B | 2.8B | 3.6B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |